"We Are Undeniable": ALS Association Launches Campaign to Confront Insurance Denials

Summary

The ALS Association launched a campaign to help families appeal insurance denials for the first FDA-approved gene-targeted ALS treatment, after reviewing commercial insurers that impose additional requirements beyond FDA requirements.